Vesugen
Also known as: Lys-Glu-Asp, Vascular bioregulator, Khavinson vascular peptide
- Half-life:
- Unknown
Administration Routes
Mechanism of Action
Tripeptide bioregulator targeting vascular endothelium; normalizes gene expression in smooth muscle and endothelial cells; reduces lipid accumulation in vessel walls
A Khavinson vascular peptide bioregulator that supports endothelial integrity and cardiovascular health. Studied for atherosclerosis prevention and vascular aging.
Primary Research Areas
- vascular repair
- endothelial function
- cardiovascular anti-aging
- atherosclerosis reduction
Risk Profile
Generally considered lower risk in research contexts. Consult a healthcare professional before use.
Regulatory Status
Russian vascular peptide bioregulator (Lys-Glu-Asp) from Khavinson Institute. Developed for vascular endothelium health. Not FDA-approved. Not on any FDA list. Research chemical.
Regulatory status reflects publicly available information and may change. This is not legal or medical advice.
Where to Find Vesugen
No active associated providers listed yet.